<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    111, Inc.

    verified_userVerify Profile
    Companies » Consumer Services » Food & Drug Retailers » Drug Retailers

    About 111, Inc.

    111,Inc., co-founded by Gang Yu and Junling Liu in 2010, is a leading digital and mobile healthcare platform in China. By applying advanced Internet and information technology, 111,Inc. is devoted to online medical services and online pharmacy through optimized supply chain and cloud services, to increase the efficiency and transparency of drug retail and distribution. 111,Inc. aims to deliver the best and comprehensive healthcare solutions to Chinese people. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $2,300,000,000
    • SIC CODE
      5912
    • NIN CODE
      ####
    • LEADERSHIP
      Dr. Gang Yu and Junling Liu
    • FOUNDED
      2010
    • EMPLOYEES
      1001-5000
    • SECTOR
      Food & Drug Retailers
    • SUBSECTOR
      Drug Retailers

    Company Tags

    No articles found.

    Albireo Pharma, Inc.

    Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development a...

    Albireo is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    Proteostasis Therapeutics, Inc.

    Proteostasis Therapeutics, Inc.

    Proteostasis Therapeutics, Inc. is an innovative biopharmaceutical company committ...

    Proteostasis Therapeutics, Inc. is an innovativ...

    Filing Type:    PU
    Caladrius Biosciences, Inc.

    Caladrius Biosciences, Inc.

    Caladrius is a clinical-stage biopharmaceutical company committed to the developme...

    Caladrius is a clinical-stage biopharmaceutical...

    Filing Type:    PU
    NowRx, Inc.

    NowRx, Inc.

    NowRx provides a trusted, reliable way to have your prescriptions delivered, from ...

    NowRx provides a trusted, reliable way to have ...

    Amount Raised:    $2,233,127.00
    Fundraising Status:    EC
    Filing Type:    RACF
    China Jo-Jo Drugstores, Inc.

    China Jo-Jo Drugstores, Inc.

    Incorporated in 2006 with headquarters in Hangzhou, China, China Jo-Jo Drugstores,...

    Incorporated in 2006 with headquarters in Hangz...

    Filing Type:    PU
    Fred's, Inc.

    Fred's, Inc.

    Tracing our history back to an original store in Coldwater, Mississippi in 1947, F...

    Tracing our history back to an original store i...

    Filing Type:    PU
    Bublish Inc.

    Bublish Inc.

    Bubllish is a book creation & marketing platform where authors can reach new reade...

    Bubllish is a book creation & marketing platfor...

    Amount Raised:    $300,000
    Fundraising Status:    SD
    Filing Type:    CF
    Punch TV Studios Inc

    Punch TV Studios Inc

    The mission of Punch TV Studios, Inc. is to be a global producer and distributor o...

    The mission of Punch TV Studios, Inc. is to be ...

    Fundraising Status:    EC
    Filing Type:    RD
    Digimarc Corporation

    Digimarc Corporation

    Digimarc Corp. (NASDAQ: DMRC), based in Beaverton, Oregon, is inventor of the Digi...

    Digimarc Corp. (NASDAQ: DMRC), based in Beavert...

    Filing Type:    PU
    So-Young International Inc.

    So-Young International Inc.

    So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”) is ...

    So-Young International Inc. (NASDAQ: SY) (“So...

    Filing Type:    PU
    RadNet, Inc.

    RadNet, Inc.

    RadNet is the national leader in outpatient imaging. Backed by 30 years of experie...

    RadNet is the national leader in outpatient ima...

    Filing Type:    PU
    Bellerophon Therapeutics, Inc.

    Bellerophon Therapeutics, Inc.

    At Bellerophon Therapeutics, we aim to transform the lives of people suffering fro...

    At Bellerophon Therapeutics, we aim to transfor...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.